HomeCompareHOLX vs KHC

HOLX vs KHC: Dividend Comparison 2026

HOLX yields 2.65% · KHC yields 7.16%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KHC wins by $8.4K in total portfolio value
10 years
HOLX
HOLX
● Live price
2.65%
Share price
$75.55
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.6K
Annual income
$314.03
Full HOLX calculator →
KHC
KHC
● Live price
7.16%
Share price
$22.34
Annual div
$1.60
5Y div CAGR
-0.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32.0K
Annual income
$1,114.92
Full KHC calculator →

Portfolio growth — HOLX vs KHC

📍 KHC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHOLXKHC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HOLX + KHC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HOLX pays
KHC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HOLX
Annual income on $10K today (after 15% tax)
$225.02/yr
After 10yr DRIP, annual income (after tax)
$266.93/yr
KHC
Annual income on $10K today (after 15% tax)
$608.77/yr
After 10yr DRIP, annual income (after tax)
$947.68/yr
At 15% tax rate, KHC beats the other by $680.76/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HOLX + KHC for your $10,000?

HOLX: 50%KHC: 50%
100% KHC50/50100% HOLX
Portfolio after 10yr
$27.8K
Annual income
$714.47/yr
Blended yield
2.57%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on HOLX right now

HOLX
Analyst Ratings
18
Buy
23
Hold
1
Sell
Consensus: Hold
Price Target
$77.80
+3.0% upside vs current
Range: $76.00 — $79.00
Altman Z
4.2
Piotroski
7/9
KHC
Analyst Ratings
4
Buy
21
Hold
9
Sell
Consensus: Hold
Price Target
$24.38
+9.1% upside vs current
Range: $23.00 — $27.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HOLX buys
0
KHC buys
10
PoliticianChamberTickerTypeAmountDate
Ro Khanna🏢 House$KHC▼ Sell$1,001 - $15,0002025-10-07
Ro Khanna🏢 House$KHC▼ Sell$1,001 - $15,0002025-08-26
Ro Khanna🏢 House$KHC▲ Buy$1,000 - $15,0002025-08-04
Ro Khanna🏢 House$KHC▲ Buy$1,001 - $15,0002025-07-25
Michael McCaul🏢 House$KHC▼ Sell$100,001 - $250,0002025-05-19
Rob Bresnahan🏢 House$KHC▲ Buy$1,001 - $15,0002025-05-15
Rob Bresnahan🏢 House$KHC▼ Sell$1,001 - $15,0002025-04-08
Michael McCaul🏢 House$KHC▼ Sell$100,001 - $250,0002025-04-02
Michael McCaul🏢 House$KHC▲ Buy$50,001 - $100,0002025-03-04
Michael McCaul🏢 House$KHC▲ Buy$100,001 - $250,0002024-05-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHOLXKHC
Forward yield2.65%7.16%
Annual dividend / share$2.00$1.60
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-0.1%
Portfolio after 10y$23.6K$32.0K
Annual income after 10y$314.03$1,114.92
Total dividends collected$2.9K$9.2K
Payment frequencyquarterlyquarterly
SectorHealthcareConsumer Staples
Analyst consensusHoldHold
Analyst price target$77.80$24.38

Year-by-year: HOLX vs KHC ($10,000, DRIP)

YearHOLX PortfolioHOLX Income/yrKHC PortfolioKHC Income/yrGap
1← crossover$10,965$264.73$11,415$715.49$450.00KHC
2$12,004$271.27$12,977$762.57$973.00KHC
3$13,121$277.55$14,695$809.37$1.6KKHC
4$14,323$283.54$16,579$855.69$2.3KKHC
5$15,615$289.27$18,641$901.35$3.0KKHC
6$17,003$294.73$20,892$946.20$3.9KKHC
7$18,493$299.93$23,345$990.10$4.9KKHC
8$20,093$304.87$26,012$1,032.91$5.9KKHC
9$21,809$309.57$28,907$1,074.55$7.1KKHC
10$23,649$314.03$32,046$1,114.92$8.4KKHC

HOLX vs KHC: Complete Analysis 2026

HOLXHealthcare

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Full HOLX Calculator →

KHCConsumer Staples

The Kraft Heinz Company, together with its subsidiaries, manufactures and markets food and beverage products in the United States, Canada, the United Kingdom, and internationally. Its products include condiments and sauces, cheese and dairy products, meals, meats, refreshment beverages, coffee, and other grocery products. The company also offers dressings, healthy snacks, and other categories; and spices and other seasonings. It sells its products through its own sales organizations, as well as through independent brokers, agents, and distributors to chain, wholesale, cooperative and independent grocery accounts, convenience stores, drug stores, value stores, bakeries, pharmacies, mass merchants, club stores, and foodservice distributors and institutions, including hotels, restaurants, hospitals, health care facilities, and government agencies; and online through various e-commerce platforms and retailers. The company was formerly known as H.J. Heinz Holding Corporation and changed its name to The Kraft Heinz Company in July 2015. The Kraft Heinz Company was founded in 1869 and is headquartered in Pittsburgh, Pennsylvania.

Full KHC Calculator →
📬

Get this HOLX vs KHC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HOLX vs SCHDHOLX vs JEPIHOLX vs OHOLX vs KOHOLX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.